Frazier Life Sciences Management’s Prothena Corp PRTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-127,900	Closed	-$6.17M	–	53
2023 Q3	$6.17M	Hold	127,900	–	–	0.41%	40
2023 Q2	$8.73M	Hold	127,900	–	–	0.52%	35
2023 Q1	$6.2M	Hold	127,900	–	–	0.45%	39
2022 Q4	$7.71M	Buy	+127,900	New	+$7.71M	0.48%	34